Pathological work up of the primary tumor: Getting the proper information out of it
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 20, S82-S86
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Triple-negative breast cancer: disease entity or title of convenience?Nature Reviews Clinical Oncology, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplificationBreast Cancer Research and Treatment, 2009
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Conservative surgery in patients with multifocal/multicentric breast cancerBreast Cancer Research and Treatment, 2008
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerAnnals of Oncology, 2007
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJournal of Clinical Pathology, 2006